Penserra Capital Management LLC Pacira Bio Sciences, Inc. Transaction History

Penserra Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$51.49 - $81.64 $1.25 Million - $1.99 Million	-24,342 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $1.46 Million - $1.86 Million	24,342 New	24,342 $1.86 Million
Q4 2021 Feb 15, 2022	SELL	$47.97 - $62.21 $48,929 - $63,454	-1,020 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $1,092 - $1,226	20 Added 2.0%	1,020 $57,000
Q2 2021 Aug 12, 2021	BUY	$59.18 - $69.99 $1,183 - $1,399	20 Added 2.04%	1,000 $60,000
Q1 2021 May 13, 2021	SELL	$59.31 - $78.82 $889 - $1,182	-15 Reduced 1.51%	980 $68,000
Q4 2020 Feb 12, 2021	BUY	$50.47 - $66.26 $31,745 - $41,677	629 Added 171.86%	995 $59,000
Q3 2020 Nov 13, 2020	BUY	$51.97 - $63.0 $19,021 - $23,058	366 New	366 $22,000

263

50.4M

429K

391K

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $892M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.